Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria

Claudia Hawkins, Oche Agbaji, Placid Ugoagwu, Chloe L Thio, Muazu M. Auwal, Charles Ani, Chinedum Okafo, Erika Wallender, Robert L. Murphy

Research output: Contribution to journalArticle

Abstract

We describe the prevalence and risk factors for advanced liver fibrosis (≥9.3 kPa) using transient elastography in human immunodeficiency virus (HIV)-monoinfected and HIV/HBV (hepatitis B virus)-coinfected, antiretroviral naive adults in Nigeria. HBV coinfection and HBV DNA levels significantly increased the risk of advanced fibrosis in HIV and HIV/HBV patients, respectively.

Original languageEnglish (US)
JournalClinical Infectious Diseases
Volume57
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Elasticity Imaging Techniques
Nigeria
Coinfection
Hepatitis B virus
Liver Cirrhosis
HIV
Fibrosis
DNA

Keywords

  • Africa
  • HBV
  • HIV
  • liver fibrosis

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria. / Hawkins, Claudia; Agbaji, Oche; Ugoagwu, Placid; Thio, Chloe L; Auwal, Muazu M.; Ani, Charles; Okafo, Chinedum; Wallender, Erika; Murphy, Robert L.

In: Clinical Infectious Diseases, Vol. 57, No. 12, 12.2013.

Research output: Contribution to journalArticle

Hawkins, Claudia ; Agbaji, Oche ; Ugoagwu, Placid ; Thio, Chloe L ; Auwal, Muazu M. ; Ani, Charles ; Okafo, Chinedum ; Wallender, Erika ; Murphy, Robert L. / Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria. In: Clinical Infectious Diseases. 2013 ; Vol. 57, No. 12.
@article{698d12e78ac84d39a3708eba8ef8e5be,
title = "Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria",
abstract = "We describe the prevalence and risk factors for advanced liver fibrosis (≥9.3 kPa) using transient elastography in human immunodeficiency virus (HIV)-monoinfected and HIV/HBV (hepatitis B virus)-coinfected, antiretroviral naive adults in Nigeria. HBV coinfection and HBV DNA levels significantly increased the risk of advanced fibrosis in HIV and HIV/HBV patients, respectively.",
keywords = "Africa, HBV, HIV, liver fibrosis",
author = "Claudia Hawkins and Oche Agbaji and Placid Ugoagwu and Thio, {Chloe L} and Auwal, {Muazu M.} and Charles Ani and Chinedum Okafo and Erika Wallender and Murphy, {Robert L.}",
year = "2013",
month = "12",
doi = "10.1093/cid/cit564",
language = "English (US)",
volume = "57",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria

AU - Hawkins, Claudia

AU - Agbaji, Oche

AU - Ugoagwu, Placid

AU - Thio, Chloe L

AU - Auwal, Muazu M.

AU - Ani, Charles

AU - Okafo, Chinedum

AU - Wallender, Erika

AU - Murphy, Robert L.

PY - 2013/12

Y1 - 2013/12

N2 - We describe the prevalence and risk factors for advanced liver fibrosis (≥9.3 kPa) using transient elastography in human immunodeficiency virus (HIV)-monoinfected and HIV/HBV (hepatitis B virus)-coinfected, antiretroviral naive adults in Nigeria. HBV coinfection and HBV DNA levels significantly increased the risk of advanced fibrosis in HIV and HIV/HBV patients, respectively.

AB - We describe the prevalence and risk factors for advanced liver fibrosis (≥9.3 kPa) using transient elastography in human immunodeficiency virus (HIV)-monoinfected and HIV/HBV (hepatitis B virus)-coinfected, antiretroviral naive adults in Nigeria. HBV coinfection and HBV DNA levels significantly increased the risk of advanced fibrosis in HIV and HIV/HBV patients, respectively.

KW - Africa

KW - HBV

KW - HIV

KW - liver fibrosis

UR - http://www.scopus.com/inward/record.url?scp=84890032612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890032612&partnerID=8YFLogxK

U2 - 10.1093/cid/cit564

DO - 10.1093/cid/cit564

M3 - Article

C2 - 24014732

AN - SCOPUS:84890032612

VL - 57

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 12

ER -